Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Oken

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot studyM J O'Connell, J P Colgan, M M Oken, et al.
Investigational New Drugs|January 1, 1994
Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885A Y Chang, Z N Tu, G T Bryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemiaJ D Hines, M M Oken, J J Mazza, et al.
American Journal of Hematology|May 1, 1987
In vitro correlates of low dose ara-C efficacy: clinical, cytogenetic, and bone marrow culture analysisD J Weisdorf, R T Perri, D C Arthur, et al.
American Journal of Hematology|March 1, 1991
High-dose dexamethasone for refractory or relapsing multiple myelomaW R Friedenberg, R A Kyle, W H Knospe, et al.
Blood|November 15, 1995
Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study GroupN E Kay, M M Oken, N Bone, et al.
American Journal of Clinical Oncology|December 1, 1995
Phase III study comparing vincristine, doxorubicin (Adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma. An Eastern Cooperative Oncology Group studyM A Gertz, L A Kalish, R A Kyle, et al.
Blood|October 1, 1992
Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patientsD Billadeau, L Quam, W Thomas, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1995
The Minnesota Cancer Pain Project: design, methods, and education strategiesT E Elliott, D M Murray, M M Oken, et al.
Leukemia|November 1, 1992
Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experienceJ M Rowe, J W Andersen, P A Cassileth, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot studyM J O'Connell, J P Colgan, M M Oken, et al.
Investigational New Drugs|January 1, 1994
Phase II study of echinomycin in the treatment of renal cell carcinoma ECOG study E2885A Y Chang, Z N Tu, G T Bryan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemiaJ D Hines, M M Oken, J J Mazza, et al.
American Journal of Hematology|May 1, 1987
In vitro correlates of low dose ara-C efficacy: clinical, cytogenetic, and bone marrow culture analysisD J Weisdorf, R T Perri, D C Arthur, et al.
American Journal of Hematology|March 1, 1991
High-dose dexamethasone for refractory or relapsing multiple myelomaW R Friedenberg, R A Kyle, W H Knospe, et al.
Blood|November 15, 1995
Circulating CD19+ blood cell levels in myeloma. ECOG Myeloma Clinical Trials Laboratory Study GroupN E Kay, M M Oken, N Bone, et al.
American Journal of Clinical Oncology|December 1, 1995
Phase III study comparing vincristine, doxorubicin (Adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma. An Eastern Cooperative Oncology Group studyM A Gertz, L A Kalish, R A Kyle, et al.
Blood|October 1, 1992
Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patientsD Billadeau, L Quam, W Thomas, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 1, 1995
The Minnesota Cancer Pain Project: design, methods, and education strategiesT E Elliott, D M Murray, M M Oken, et al.
Leukemia|November 1, 1992
Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experienceJ M Rowe, J W Andersen, P A Cassileth, et al.
Pageof 15